Cardiology Headline News

In patients with atrial fibrillation who had ablation, those assigned a Mediterranean diet enriched with extra-virgin olive oil were less likely to have arrhythmia recurrence than those with no dietary restrictions, researchers reported.

SAN DIEGO — Measures of pulmonary vascular disease and right ventricular function improved with longer lifetime menses in pulmonary hypertension, according to research presented at the American Thoracic Society International Conference.

SAN FRANCISCO — Effective strategies to prevent and manage hypertensive disorders of pregnancy are often underutilized, but a new CDC initiative aims to harness solutions that work and package them in one place for busy clinicians.

Patients with both diabetes and CAD appeared at significantly greater risk for dementia, especially vascular dementia, according to study findings published in European Journal of Preventive Cardiology.

Individuals prescribed the antidiabetes treatment metformin less likely developed a myeloproliferative neoplasm —potentially also reducing a person’s chances for developing certain cancers — according to data published in Blood Advances.

Implicity announced it received 510(k) clearance from the FDA for its new AI algorithm to assess risk for future HF events from data gathered from various cardiac implantable electronic devices.

No athlete with a positive test for genetic heart disease but a negligible clinical phenotype had a genetic heart disease-associated death or cardiac event in more than 1,500 person-years of follow-up, researchers reported.

A new prosthetic aortic valve with a wider range of intermediate sizing was noninferior at 30 days vs. other contemporary transcatheter aortic valves, a speaker reported.

DESTIN, Fla. — Pinpointing rare subtypes of Ehlers-Danlos syndrome is crucial, as the consequences of overlooking them could be deadly, according to a speaker at the Congress of Clinical Rheumatology East.

In patients with type 2 diabetes who underwent ablation for atrial fibrillation, those taking a GLP-1 receptor agonist had lower risk for AF recurrence, mortality and other outcomes, researchers reported at Heart Rhythm 2024.